A Pharmacokinetic (PK) Study Evaluating Naproxen and Esomeprazole Plasma Levels

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 31, 2008

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions
Arthritis
Interventions
DRUG

PN 400

A single tablet containing delayed-release naproxen (500mg) plus immediate-release esomeprazole (20mg)

DRUG

EC naproxen plus EC esomeprazole

Enteric-coated naproxen tablet (500mg) plus enteric-coated esomeprazole capsule (20mg)

DRUG

EC naproxen

Enteric-coated naproxen tablet (500mg)

DRUG

EC esomeprazole

Enteric-coated esomeprazole capsule (20mg)

Trial Locations (1)

78744

PPD, Austin

Sponsors

Lead Sponsor

All Listed Sponsors
lead

POZEN

INDUSTRY